TITLE

Therapeutic Non-equivalence of Digoxin Tablets

AUTHOR(S)
Dewar, H. A.
PUB. DATE
February 1974
SOURCE
British Medical Journal;2/2/1974, Vol. 1 Issue 5900, p197
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64109488

 

Related Articles

  • Evaluation of digoxin capsules in outpatient. Rodgers, Elaine M.; Dobbs, Sylvia M.; Kenyon, W.I.; Poston, J.W. // British Medical Journal;7/23/1977, Vol. 2 Issue 6081, p234 

    Reports the evaluation of digoxin capsules in outpatients. Differences in the dose of digoxin tablets to maintain serum concentrations; Result of the variable absorption of digoxin; Therapeutic uses of digoxin.

  • Absorption of Orally Administered Digoxin After Massive Resection of the Small Bowel. Krausz, Michael M.; Berry, Elliot; Freund, Uri; Levy, Micha // American Journal of Gastroenterology;Feb1979, Vol. 71 Issue 2, p220 

    Digoxin absorption was studied in a patient after massive small bowel resection (with only 15 cm. of jejunum left) after mesenteric thrombosis. Oral administration of 0.25 mg. digoxin tablets resulted in therapeutic blood levels between 0.7 and 2.2 ng./ml. Measurement of the urinary excretion of...

  • No shortage of digoxin tablets expected, despite FDA rule. Chi, Judy // Drug Topics;8/19/2002, Vol. 146 Issue 16, p33 

    Comments on the Food and Drug Administration's ruling that regulates digoxin tablets in the U.S. Key stipulations of the regulation on digoxin tablets; Impact on patient safety; Policy implications on medical care.

  • Digoxin dosage in infants.  // British Medical Journal;4/14/1979, Vol. 1 Issue 6169, p987 

    Examines digoxin dosage in infants. Evaluation of the therapeutic and toxic doses of digoxin; Importance of assessing the response of a child to the first dose of digoxin; Treatment methods based on clinical responses.

  • Effect of Therapeutic Digoxin Antibodies on Digoxin Assays.  // JAMA: Journal of the American Medical Association;3/23/90-3/30/90, Vol. 263 Issue 12, p1686 

    Presents an abstract of the article 'Effect of Therapeutic Digoxin Antibodies on Digoxin Assays,' by John R. Hansell, published in a 1989 issue of the journal 'Archives of Pathology and Laboratory Medicine.'

  • Digoxin Tablet Bioavailability: Single-Dose and Steady-State Assessment. Preibisz, Jacek J.; Butler, Vincent P.; Lindenbaum, John // Annals of Internal Medicine;Oct74, Vol. 81 Issue 4, p469 

    Focuses on a study which tested the bioavailability of four lots of digoxin tablets with different dissolution rates. Subjects and method; Results; Discussion.

  • DIGOXIN. Aronson, J.K.; Hardman, M. // BMJ: British Medical Journal (International Edition);11/7/92, Vol. 305 Issue 6862, p1149 

    Focuses on the measurement of plasma digoxin concentration. Effect of digoxin on patients with atrial fibrillation; Relationship between the plasma concentration of digoxin and its therapeutic effects on patients with sinus rhythm; Aspects to consider in the timing of blood sampling for plasma...

  • Interactions with digozin: more problems. George, Charles F. // British Medical Journal (Clinical Research Edition);1/30/1982, Vol. 284 Issue 6312, p291 

    Analyzes the implications of physiological interactions associated with digoxin administration. Measurement of therapeutic range and dosage requirements; Impact of digoxin on the heart and central nervous system; Analysis of renal and non-renal excretion of digoxin; Significance of plasma and...

  • Evaluation of Digoxin Dosing in Two Egyptian Hospitals A Pilot Study. Farid, Samar F.; Abbassia, Maggie M.; Sabrya, Nirmeen A.; Elkhaleq, Shaimaa Abd // Australian Journal of Basic & Applied Sciences;2009, Vol. 3 Issue 3, p1838 

    Introduction: Digoxin is one of the digitalis cardiac glycosides indicated in heart failure and atrial fibrillation. Due to individual variability in digoxin pharmacokinetics, digoxin doses need to be calculated based on patient's weight, renal function and indication. Furthermore, therapeutic...

  • Serum digoxin level among patients referred to Kashan cardiovascular clinic during 2009-10. Rajabi-Moghadam, H.; Raygan, F.; Moravveji, A. R.; Nasr-Esfahani, F. // Feyz Journal of Kashan University of Medical Sciences;Apr2012, Vol. 16 Issue 2, p154 

    Background: Considering that the Digoxin's therapeutic level is very close to its toxic level, it is important to determine the digoxin dose. Digoxin serum level is affected by multiple pharmacokinetic factors. Therefore, this study aimed to evaluate the serum digoxin level and its relation with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics